Patent payouts could damage UK industry
In February, in the first ever case of its kind, the English Patents Court ordered the payment of £1.5m ‘compensation’ to two former employees of GE Healthcare. The claim was made under little used pr...
LNG offers Europe some security of supply
Faced with increasing world demand for gas, Europe has become more and more concerned with securing adequate and reliable supplies, particularly for the UK, Germany, France and Italy. With the excepti...
Should we bail out biotech?
UK biotechnology companies are coming to the government with begging bowls in hand
Heavyweight drugs
When C&I broke the story in 2007 that scientists had significantly extended the lifespan of animals by feeding them natural isotopes (C&I 2007, 6, 7), it sparked a frenzy of interest amongst the natio...
Biomass and America’s energy future discussed
The controversy surrounding first generation biofuels, such as the production of ethanol from corn, a food crop, has clouded the biomass picture and could lead decision makers, investors and researche...
Precious anticancer drugs
In the late 1960s, Barnett Rosenberg and coworkers at Michigan State University in the US made a serendipitous discovery: the application of an electric field produced by passing a current through pla...
Nanotubes are becoming 1st choice
Researchers are discovering that carbon nanotubes (CNTs) could be more affordable and useful to many industrial areas, including flame retardant materials markets. Tom Cox Researchers are discove...
All aboard for Chemistry
Chemistry is now poised to address some of the 21st century’s great societal challenges. Delivering these advances, however, requires a bold change of approach by the chemical research and industri...